The optimal therapeutic regimen after coronary drug-eluting stent implantation in patients requiring chronic oral anticoagulation (OAC) remains uncertain. Whether the degree of P2Y12-receptor inhibition is associated with increased risk of… Click to show full abstract
The optimal therapeutic regimen after coronary drug-eluting stent implantation in patients requiring chronic oral anticoagulation (OAC) remains uncertain. Whether the degree of P2Y12-receptor inhibition is associated with increased risk of stent thrombosis (ST) in such patients is currently unclear
               
Click one of the above tabs to view related content.